Dermatology Approved Deal Benchmarks — Ex-US (2026)
Median upfront of $1.5B with total deal values reaching $4.2B in Ex-US territory.
Median Upfront
$1.5B
Total Deal Value
$3.7B
Royalty Range
11%–20.2%
Territory Multiplier
0.45x
Understanding Dermatology Deal Benchmarks at Approved
Approved Dermatology licensing deals in Ex-US territory command a median upfront payment of $1.5B, with values ranging from $1.1B at the low end to $1.8B for premium assets. These benchmarks reflect the risk-adjusted value of clinical-stage assets in the dermatology therapeutic area, where development costs, competitive dynamics, and market potential all factor into deal pricing.
Full Market Analysis
Detailed deal economics, territory impact analysis, and royalty structure breakdown.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Full Benchmark Data
Full Benchmark Table
Low, median, and high ranges for upfront payments, total deal values, and royalty rates.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Comparable Deals
See All Comparable Deals
View 3 comparable Dermatology transactions with upfront payments, total values, and deal structures.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Frequently Asked Questions
What is the average upfront payment for Approved Dermatology deals in Ex-US territory?
More Expert Insights
Territory impact analysis, royalty negotiation strategies, and deal structure guidance.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
7-day money-back guarantee · Cancel anytime
Related Benchmarks
$17M upfront
Dermatology · Preclinical · Ex-US
$45M upfront
Dermatology · Phase 1 · Ex-US
$169M upfront
Dermatology · Phase 2 · Ex-US
$563M upfront
Dermatology · Phase 3 · Ex-US
$934M upfront
Oncology · Approved · Ex-US
$664M upfront
Neurology/CNS · Approved · Ex-US
$1.5B upfront
Immunology · Approved · Ex-US
$1.6B upfront
Metabolic/Obesity · Approved · Ex-US
Run Your Own Benchmark
These benchmarks are starting points. Get a customized valuation for your specific asset, indication, and deal structure.
Open Deal CalculatorCite This Data
Ambrosia Ventures. (2026). Dermatology Approved Deal Benchmarks — Ex-US (2026). Retrieved from https://calculator.ambrosiaventures.co/data/dermatology-approved-deals-ex-us
<a href="https://calculator.ambrosiaventures.co/data/dermatology-approved-deals-ex-us">Dermatology Approved Deal Benchmarks — Ex-US (2026)</a> — Ambrosia Ventures (2026)
<iframe src="https://calculator.ambrosiaventures.co/api/embed/chart?type=phase-upfront&ta=dermatology&theme=light" width="600" height="400" frameborder="0" style="border:1px solid #e2e8f0;border-radius:12px;"></iframe>
Data sourced from 1,900+ verified biopharma transactions. Updated monthly.